Checking in on U.S. knee replacement, smaller form factor technology and the outlook  for the trauma segment.

What We’re Watching in 2H 2026

Checking in on U.S. knee replacement, smaller form factor technology and the outlook for the trauma segment.

A quarterly recap of hip product launches

Stryker Gaining Ground in OUS Hip Replacement Market

Our chart of the month looks at the ten-year sales history for OUS hip replacement among Zimmer Biomet, Stryker and DePuy Synthes.

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Takeaways from THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT

Highlights from the brand new 2026 edition include the health of end markets, dynamics at play in the trauma segment, and the tantalizing promise of orthobiologics.

Orthoflash®
The credit consists of a $15 million growth capital term loan, a $30 million undrawn line of credit, and a $5 million accordion feature.
Shoulder Innovations Closes up to $50 Million Credit Facility

The credit consists of a $15 million growth capital term loan, a $30 million undrawn line of credit, and a $5 million accordion feature.

,
Elevation Spine Saber-C Spinal Fusion Implant
Elevation Spine Surpasses 5,000 Saber-C Implantations

The Saber-C system combines the stability of traditional anterior cervical plating with a zero-profile interbody construct.

,
Life Spine Receives FDA 510(k) Clearance for VersaLift Expandable Interbody System Featuring a 6mm Starting Height
Life Spine Earns FDA 510(k) for VersaLift Expandable Interbody

VersaLift offers one of the smallest starting heights available for a TLIF expandable interbody implant, beginning at just 6mm.

,
Moximed MISHA Knee System
Study Results for Knee OA Patients Treated with Moximed MISHA Knee

MISHA is shown to be effective for knee OA patients who failed non-surgical treatments, but are not indicated or are unwilling to get a knee replacement.

,
Bio-Gate: Update on the HIPrevision clinical trial for HyProtect-coated hip revision implants
Bio-Gate: Update on HIPrevision Clinical Trial for HyProtect

The project is on track to reach the next milestone toward CE Mark approval of HyProtect-coated revision implants.

,
Competitive Landscape
Industry Voices

Contact Us

  • This field is for validation purposes and should be left unchanged.

0